Introducing the state-of-the-art Health Medical Ultrasonic Stimulator - the ultimate solution for nerve block plexus needle stimulation.
| Place of Origin |
China Jiangsu |
| Brand Name |
HUAXING |
| Model Number |
OEM |
| Disinfecting Type |
EOS |
| Properties |
Medical Adhesive & Suture Material |
| Size |
17x8.5x4.8 cm |
| Stock |
Yes |
| Shelf Life |
3 years |
| Material |
PC |
| Quality Certification |
ce |
| Instrument classification |
Class II |
| Safety standard |
ISO 13485 |
| Product Name |
nerve block plexus needle stimulator |
| Usage |
Anesthesia and pain management |
| Type |
electronic stimulator |
| Licence Number |
2001-0264 |
Established in 1999, Hua Xing boasts a registered capital of USD 7.5 million. Our extensive 25,000 square meter facility employs 200 dedicated workers.
and 50 skilled administrative staff. Our company prides itself on ISO level 8, 7, and 5 clean rooms, all meticulously designed to meet GMP and ISO standards,
ensuring unparalleled quality and safety. Our diverse product line includes anesthesia, gynecology, surgery, ICU, and CT products. To date, 40 of our products have earned CFDA certification, with the Hua Xing brand recognized as a distinguished trademark.
ICU and CT products totally 40 products have the CFDA certificates, our brand Hua Xing acquired famous trade mark.
To guarantee superior quality control, we invested USD 450,000 in a cutting-edge testing center, equipped with all necessary tools. Our QC staff, certified by the CFDA institution, excel in raw material inspection, process inspection, and final product checks. We comply with GMP and ISO 13485 standards, and some products have earned the CE mark from TUV Rheinland. Our products enjoy global demand. Our team includes 30 highly skilled administrative professionals and 20 technical experts dedicated to continuous innovation. Annually, we invest USD 400,000 to stay ahead in the market, holding 48 patents to date. Hua Xing's commitment to quality has earned us a stellar reputation, with positive feedback from hospitals. Moving forward, we aim to enhance product visibility, uphold our brand image, and drive continuous innovation.
){kind=link}